查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1392386

全球體外毒性測試市場研究報告 - 2023 年至 2030 年產業分析、規模、佔有率、成長、趨勢和預測

Global In Vitro Toxicity Testing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 336 Pages | 商品交期: 最快1-2個工作天內

價格

全球體外毒性測試市場需求預計將從 2022 年的 13.46 萬美元達到 2030 年近 34.34 萬美元的市場規模，2023-2030 年研究期間CAGR為 12.42%。

體外毒性測試是基於研究的有毒化學物質對培養細菌或哺乳動物細胞影響的評估。體外研究（即在玻璃中）是針對正常生物條件之外的微生物、細胞或生物分子進行的。在體外測試藥物時，藥物的濃度被限制在已知的體積內。這一點至關重要，因為所有藥物行為評估基本上都是按規定的比例進行論證的。這樣做主要是為了評估藥物開發的安全性和化學強度。毒性測試的目標是開發能夠充分保護公眾健康免受暴露於環境因素的不利影響的資料。

市場動態：

評估藥物安全性的技術進步、消費品安全性的高漲、潛在藥物排名和篩選的增加以及體外測試數量的增加是體外毒理學測試的關鍵行業驅動力。此外，研發投資的增加以及對動物試驗的反對促使了體外毒理學測試。然而，政府的嚴格監管和專業人才的缺乏是體外測試的重大障礙。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球體外毒性測試市場的各個細分市場進行了包容性評估。體外毒性測試產業的成長和趨勢為這項研究提供了整體方法。

區域分析：

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲體外毒性測試市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。體外毒性測試市場的主要參與者包括Thermo Fisher Scientific Inc.（美國）、Covance（美國）、Bio-Rad Laboratories, Inc.（美國）、GE Healthcare（美國）、Eurofins Scientific SE（盧森堡）、Merck KGaA（德國）、Charles River Laboratories International, Inc.（美國）、Catalent, Inc.（美國）、Cyprotex（英國）、SGS SA（瑞士）、QIAGEN NV（德國）、Promega Corporation（美國）、Gentronix Limited（英國） 、BioIVT（美國）和MB 研究實驗室（美國）。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第 1 章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法論
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：體外毒性測試 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按產品和服務分類的市場吸引力分析
    • 市場吸引力分析方法
    • 按毒性終點和測試進行的市場吸引力分析
    • 按行業分類的市場吸引力分析
    • 按技術分類的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：COVID-19 爆發的影響分析

第 6 章：全球體外毒性測試市場分析：按產品和服務分類

  • 按產品和服務分類的概述
  • 歷史和預測數據
  • 按產品和服務分析
  • 新冠疫情影響
  • 耗材
  • 檢測（細菌毒性檢測、酵素毒性檢測、基於細胞的 Elisa 和蛋白質印跡、受體結合檢測、組織培養檢測、其他檢測）
  • 裝置
  • 軟體
  • 服務

第 7 章：全球體外毒性測試市場分析：依方法

  • 依方法概述
  • 歷史和預測數據
  • 方法分析
  • 細胞分析
  • 生化檢測
  • 電腦模型
  • 離體模型

第 8 章：全球體外毒性測試市場分析：依毒性終點和測試

  • 毒性終點和測試概述
  • 歷史和預測數據
  • 毒性終點分析和測試
  • 阿德梅
  • 皮膚刺激、腐蝕和過敏
  • 遺傳毒性測試
  • 細胞毒性測試
  • 眼部毒性
  • 器官毒性
  • 光毒性測試
  • 皮膚毒性
  • 其他毒性終點和測試

第 9 章：全球體外毒性測試市場分析：按行業

  • 行業概況
  • 歷史和預測數據
  • 產業分析
  • 新冠疫情影響
  • 藥品與生物製藥
  • 化妝品及家居用品
  • 食物
  • 化學品

第 10 章：全球體外毒性測試市場分析：依技術分類

  • 依技術概述
  • 歷史和預測數據
  • 依技術分析
  • 細胞培養技術
  • 高通量技術
  • 毒理基因組學

第 11 章：全球體外毒性測試市場分析：依地理位置

  • 頂尖公司股票分析
  • 介紹
  • 北美銷售分析
    • 概述、歷史和預測銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概述、歷史和預測銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概述、歷史和預測銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區國家/地區銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概述、歷史和預測銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概述、歷史和預測銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 12 章：體外毒性測試公司的競爭格局

  • 體外毒性測試市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 13 章：公司簡介

  • 公司股份分析
  • 市場集中度
  • Thermo Fisher Scientific Inc. (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Covance (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Bio-Rad Laboratories Inc. (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • GE Healthcare (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Eurofins Scientific SE (Luxembourg)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Merck KGaA (Germany)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Charles River Laboratories International Inc. (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Catalent Inc. (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Cyprotex (UK)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • SGS SA (Switzerland)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • QIAGEN NV (Germany)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Promega Corporation (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Gentronix Limited (UK)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • BioIVT (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • MB Research Laboratories (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

Product Code: VMR11218376

The global demand for In Vitro Toxicity Testing Market is presumed to reach the market size of nearly USD 34.34 MN by 2030 from USD 13.46 MN in 2022 with a CAGR of 12.42% under the study period 2023 - 2030.

In vitro toxicity testing is a research-based evaluation of the effects of toxic chemicals on cultured bacteria or mammalian cells. In vitro studies (i.e., in glass) are performed against microorganisms, cells, or biological molecules outside of normal biological conditions. When testing a drug in vitro, the concentration of the drug is limited to a known volume. This is critical because all drug behaviour assessments are essentially demonstrated at defined proportions. This is primarily done to assess the safety of drug development and chemical strength. The goal of toxicity testing is to develop data that can adequately protect public health from the adverse effects of exposure to environmental factors.

MARKET DYNAMICS:

The growth in technological advancement to evaluate drug safety, the upsurge in consumer goods safety, the increase in ranking and screening of potential drugs, and the rise in the number of in-vitro tests conducted are key industry drivers for in-vitro toxicology testing. In addition, increased investment in research and development and opposition to animal testing prompted in-vitro toxicology testing. However, the government's stringent regulations and a lack of professionals are significant barriers to in-vitro testing.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of in vitro toxicity testing. The growth and trends of in vitro toxicity testing industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the in vitro toxicity testing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product & Service

  • Covid Impact
  • Consumables
  • Assays (Bacterial Toxicity Assays, Enzyme Toxicity Assays, Cell-Based Elisa & Western Blots, Receptor-Binding Assays, Tissue Culture Assays, Other Assays)
  • Equipment
  • Software
  • Services

By Method

  • Cellular Assays
  • Biochemical Assays
  • In Silico Models
  • Ex Vivo Models

By Toxicity Endpoint & Test

  • ADME
  • Skin Irritation, Corrosion, & Sensitization
  • Genotoxicity Testing
  • Cytotoxicity Testing
  • Ocular Toxicity
  • Organ Toxicity
  • Phototoxicity Testing
  • Dermal Toxicity
  • Other Toxicity Endpoints & Tests

By Industry

  • Covid Impact
  • Pharmaceuticals & Biopharmaceuticals
  • Cosmetic & Household Products
  • Food
  • Chemicals

By Technology

  • Cell Culture Technologies
  • High-Throughput Technologies
  • Toxicogenomics

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the In Vitro Toxicity Testing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the in vitro toxicity testing market include Thermo Fisher Scientific Inc. (US), Covance (US), Bio-Rad Laboratories, Inc. (US), GE Healthcare (US), Eurofins Scientific SE (Luxembourg), Merck KGaA (Germany), Charles River Laboratories International, Inc. (US), Catalent, Inc. (US), Cyprotex (UK), SGS S.A. (Switzerland), QIAGEN N.V. (Germany), Promega Corporation (US), Gentronix Limited (UK), BioIVT (US), and MB Research Laboratories (US). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . IN VITRO TOXICITY TESTING - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product & Service
    • 3.7.2 Market Attractiveness Analysis By Method
    • 3.7.3 Market Attractiveness Analysis By Toxicity Endpoint & Test
    • 3.7.4 Market Attractiveness Analysis By Industry
    • 3.7.5 Market Attractiveness Analysis By Technology
    • 3.7.6 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5. IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL IN VITRO TOXICITY TESTING MARKET ANALYSIS BY PRODUCT & SERVICE

  • 6.1 Overview by Product & Service
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Product & Service
  • 6.4 Covid Impact Historic and Forecast Sales by Regions
  • 6.5 Consumables Historic and Forecast Sales by Regions
  • 6.6 Assays (Bacterial Toxicity Assays, Enzyme Toxicity Assays, Cell-based Elisa & Western Blots, Receptor-binding Assays, Tissue Culture Assays, Other Assays) Historic and Forecast Sales by Regions
  • 6.7 Equipment Historic and Forecast Sales by Regions
  • 6.8 Software Historic and Forecast Sales by Regions
  • 6.9 Services Historic and Forecast Sales by Regions

7 . GLOBAL IN VITRO TOXICITY TESTING MARKET ANALYSIS BY METHOD

  • 7.1 Overview by Method
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Method
  • 7.4 Cellular Assays Historic and Forecast Sales by Regions
  • 7.5 Biochemical Assays Historic and Forecast Sales by Regions
  • 7.6 In Silico Models Historic and Forecast Sales by Regions
  • 7.7 Ex Vivo Models Historic and Forecast Sales by Regions

8 . GLOBAL IN VITRO TOXICITY TESTING MARKET ANALYSIS BY TOXICITY ENDPOINT & TEST

  • 8.1 Overview by Toxicity Endpoint & Test
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Toxicity Endpoint & Test
  • 8.4 ADME Historic and Forecast Sales by Regions
  • 8.5 Skin Irritation, Corrosion, & Sensitization Historic and Forecast Sales by Regions
  • 8.6 Genotoxicity Testing Historic and Forecast Sales by Regions
  • 8.7 Cytotoxicity Testing Historic and Forecast Sales by Regions
  • 8.8 Ocular Toxicity Historic and Forecast Sales by Regions
  • 8.9 Organ Toxicity Historic and Forecast Sales by Regions
  • 8.10. Phototoxicity Testing Historic and Forecast Sales by Regions
  • 8.11 Dermal Toxicity Historic and Forecast Sales by Regions
  • 8.12 Other Toxicity Endpoints & Tests Historic and Forecast Sales by Regions

9 . GLOBAL IN VITRO TOXICITY TESTING MARKET ANALYSIS BY INDUSTRY

  • 9.1 Overview by Industry
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by Industry
  • 9.4 Covid Impact Historic and Forecast Sales by Regions
  • 9.5 Pharmaceuticals & Biopharmaceuticals Historic and Forecast Sales by Regions
  • 9.6 Cosmetic & Household Products Historic and Forecast Sales by Regions
  • 9.7 Food Historic and Forecast Sales by Regions
  • 9.8 Chemicals Historic and Forecast Sales by Regions

10 . GLOBAL IN VITRO TOXICITY TESTING MARKET ANALYSIS BY TECHNOLOGY

  • 10.1 Overview by Technology
  • 10.2 Historical and Forecast Data
  • 10.3 Analysis by Technology
  • 10.4 Cell Culture Technologies Historic and Forecast Sales by Regions
  • 10.5 High-throughput Technologies Historic and Forecast Sales by Regions
  • 10.6 Toxicogenomics Historic and Forecast Sales by Regions

11 . GLOBAL IN VITRO TOXICITY TESTING MARKET ANALYSIS BY GEOGRAPHY

  • 11.1. Top Company Share Analysis
  • 11.2. Introduction
  • 11.3. North America Sales Analysis
    • 11.3.1. Overview, Historic and Forecast Sales Analysis
    • 11.3.2. North America By Segment Sales Analysis
    • 11.3.3. North America By Country Sales Analysis
    • 11.3.4. United State Sales Analysis
    • 11.3.5. Canada Sales Analysis
    • 11.3.6. Mexico Sales Analysis
  • 11.4. Europe Sales Analysis
    • 11.4.1. Overview, Historic and Forecast Sales Analysis
    • 11.4.2. Europe by Segment Sales Analysis
    • 11.4.3. Europe by Country Sales Analysis
    • 11.4.4. United Kingdom Sales Analysis
    • 11.4.5. France Sales Analysis
    • 11.4.6. Germany Sales Analysis
    • 11.4.7. Italy Sales Analysis
    • 11.4.8. Russia Sales Analysis
    • 11.4.9. Rest Of Europe Sales Analysis
  • 11.5. Asia Pacific Sales Analysis
    • 11.5.1. Overview, Historic and Forecast Sales Analysis
    • 11.5.2. Asia Pacific by Segment Sales Analysis
    • 11.5.3. Asia Pacific by Country Sales Analysis
    • 11.5.4. China Sales Analysis
    • 11.5.5. India Sales Analysis
    • 11.5.6. Japan Sales Analysis
    • 11.5.7. South Korea Sales Analysis
    • 11.5.8. Australia Sales Analysis
    • 11.5.9. Rest Of Asia Pacific Sales Analysis
  • 11.6. Latin America Sales Analysis
    • 11.6.1. Overview, Historic and Forecast Sales Analysis
    • 11.6.2. Latin America by Segment Sales Analysis
    • 11.6.3. Latin America by Country Sales Analysis
    • 11.6.4. Brazil Sales Analysis
    • 11.6.5. Argentina Sales Analysis
    • 11.6.6. Peru Sales Analysis
    • 11.6.7. Chile Sales Analysis
    • 11.6.8. Rest of Latin America Sales Analysis
  • 11.7. Middle East & Africa Sales Analysis
    • 11.7.1. Overview, Historic and Forecast Sales Analysis
    • 11.7.2. Middle East & Africa by Segment Sales Analysis
    • 11.7.3. Middle East & Africa by Country Sales Analysis
    • 11.7.4. Saudi Arabia Sales Analysis
    • 11.7.5. UAE Sales Analysis
    • 11.7.6. Israel Sales Analysis
    • 11.7.7. South Africa Sales Analysis
    • 11.7.8. Rest Of Middle East And Africa Sales Analysis

12 . COMPETITIVE LANDSCAPE OF THE IN VITRO TOXICITY TESTING COMPANIES

  • 12.1. In Vitro Toxicity Testing Market Competition
  • 12.2. Partnership/Collaboration/Agreement
  • 12.3. Merger And Acquisitions
  • 12.4. New Product Launch
  • 12.5. Other Developments

13 . COMPANY PROFILES OF IN VITRO TOXICITY TESTING INDUSTRY

  • 13.1. Company Share Analysis
  • 13.2. Market Concentration Rate
  • 13.3. Thermo Fisher Scientific Inc. (US)
    • 13.3.1. Company Overview
    • 13.3.2. Company Revenue
    • 13.3.3. Products
    • 13.3.4. Recent Developments
  • 13.4. Covance (US)
    • 13.4.1. Company Overview
    • 13.4.2. Company Revenue
    • 13.4.3. Products
    • 13.4.4. Recent Developments
  • 13.5. Bio-Rad Laboratories Inc. (US)
    • 13.5.1. Company Overview
    • 13.5.2. Company Revenue
    • 13.5.3. Products
    • 13.5.4. Recent Developments
  • 13.6. GE Healthcare (US)
    • 13.6.1. Company Overview
    • 13.6.2. Company Revenue
    • 13.6.3. Products
    • 13.6.4. Recent Developments
  • 13.7. Eurofins Scientific SE (Luxembourg)
    • 13.7.1. Company Overview
    • 13.7.2. Company Revenue
    • 13.7.3. Products
    • 13.7.4. Recent Developments
  • 13.8. Merck KGaA (Germany)
    • 13.8.1. Company Overview
    • 13.8.2. Company Revenue
    • 13.8.3. Products
    • 13.8.4. Recent Developments
  • 13.9. Charles River Laboratories International Inc. (US)
    • 13.9.1. Company Overview
    • 13.9.2. Company Revenue
    • 13.9.3. Products
    • 13.9.4. Recent Developments
  • 13.10. Catalent Inc. (US)
    • 13.10.1. Company Overview
    • 13.10.2. Company Revenue
    • 13.10.3. Products
    • 13.10.4. Recent Developments
  • 13.11. Cyprotex (UK)
    • 13.11.1. Company Overview
    • 13.11.2. Company Revenue
    • 13.11.3. Products
    • 13.11.4. Recent Developments
  • 13.12. SGS S.A. (Switzerland)
    • 13.12.1. Company Overview
    • 13.12.2. Company Revenue
    • 13.12.3. Products
    • 13.12.4. Recent Developments
  • 13.13. QIAGEN N.V. (Germany)
    • 13.13.1. Company Overview
    • 13.13.2. Company Revenue
    • 13.13.3. Products
    • 13.13.4. Recent Developments
  • 13.14. Promega Corporation (US)
    • 13.14.1. Company Overview
    • 13.14.2. Company Revenue
    • 13.14.3. Products
    • 13.14.4. Recent Developments
  • 13.15. Gentronix Limited (UK)
    • 13.15.1. Company Overview
    • 13.15.2. Company Revenue
    • 13.15.3. Products
    • 13.15.4. Recent Developments
  • 13.16. BioIVT (US)
    • 13.16.1. Company Overview
    • 13.16.2. Company Revenue
    • 13.16.3. Products
    • 13.16.4. Recent Developments
  • 13.17. MB Research Laboratories (US)
    • 13.17.1. Company Overview
    • 13.17.2. Company Revenue
    • 13.17.3. Products
    • 13.17.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Product & Service (USD MN)
  • Covid Impact Market Sales by Geography (USD MN)
  • Consumables Market Sales by Geography (USD MN)
  • Assays (Bacterial Toxicity Assays, Enzyme Toxicity Assays, Cell-based Elisa & Western Blots, Receptor-binding Assays, Tissue Culture Assays, Other Assays) Market Sales by Geography (USD MN)
  • Equipment Market Sales by Geography (USD MN)
  • Software Market Sales by Geography (USD MN)
  • Services Market Sales by Geography (USD MN)
  • Analysis Market by Method (USD MN)
  • Cellular Assays Market Sales by Geography (USD MN)
  • Biochemical Assays Market Sales by Geography (USD MN)
  • In Silico Models Market Sales by Geography (USD MN)
  • Ex Vivo Models Market Sales by Geography (USD MN)
  • Analysis by Toxicity Endpoint & Test (USD MN)
  • ADME Market Sales by Geography (USD MN)
  • Skin Irritation, Corrosion, & Sensitization Market Sales by Geography (USD MN)
  • Genotoxicity Testing Market Sales by Geography (USD MN)
  • Cytotoxicity Testing Market Sales by Geography (USD MN)
  • Ocular Toxicity Market Sales by Geography (USD MN)
  • Organ Toxicity Market Sales by Geography (USD MN)
  • Phototoxicity Testing Market Sales by Geography (USD MN)
  • Dermal Toxicity Market Sales by Geography (USD MN)
  • Other Toxicity Endpoints & Tests Market Sales by Geography (USD MN)
  • Analysis by Industry (USD MN)
  • Covid Impact Market Sales by Geography (USD MN)
  • Pharmaceuticals & Biopharmaceuticals Market Sales by Geography (USD MN)
  • Cosmetic & Household Products Market Sales by Geography (USD MN)
  • Food Market Sales by Geography (USD MN)
  • Chemicals Market Sales by Geography (USD MN)
  • Analysis by Technology (USD MN)
  • Cell Culture Technologies Market Sales by Geography (USD MN)
  • High-throughput Technologies Market Sales by Geography (USD MN)
  • Toxicogenomics Market Sales by Geography (USD MN)
  • Global In Vitro Toxicity Testing Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of In Vitro Toxicity Testing Report
  • Market Research Process
  • Market Research Methodology
  • Global In Vitro Toxicity Testing Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product & Service
  • Market Attractiveness Analysis by Method
  • Market Attractiveness Analysis by Toxicity Endpoint & Test
  • Market Attractiveness Analysis by Industry
  • Market Attractiveness Analysis by Technology
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product & Service (USD MN)
  • Covid Impact Market Sales by Geography (USD MN)
  • Consumables Market Sales by Geography (USD MN)
  • Assays (Bacterial Toxicity Assays, Enzyme Toxicity Assays, Cell-based Elisa & Western Blots, Receptor-binding Assays, Tissue Culture Assays, Other Assays) Market Sales by Geography (USD MN)
  • Equipment Market Sales by Geography (USD MN)
  • Software Market Sales by Geography (USD MN)
  • Services Market Sales by Geography (USD MN)
  • Global Market Analysis by Method (USD MN)
  • Cellular Assays Market Sales by Geography (USD MN)
  • Biochemical Assays Market Sales by Geography (USD MN)
  • In Silico Models Market Sales by Geography (USD MN)
  • Ex Vivo Models Market Sales by Geography (USD MN)
  • Global Market Analysis by Toxicity Endpoint & Test (USD MN)
  • ADME Market Sales by Geography (USD MN)
  • Skin Irritation, Corrosion, & Sensitization Market Sales by Geography (USD MN)
  • Genotoxicity Testing Market Sales by Geography (USD MN)
  • Cytotoxicity Testing Market Sales by Geography (USD MN)
  • Ocular Toxicity Market Sales by Geography (USD MN)
  • Organ Toxicity Market Sales by Geography (USD MN)
  • Phototoxicity Testing Market Sales by Geography (USD MN)
  • Dermal Toxicity Market Sales by Geography (USD MN)
  • Other Toxicity Endpoints & Tests Market Sales by Geography (USD MN)
  • Global Market Analysis by Industry (USD MN)
  • Covid Impact Market Sales by Geography (USD MN)
  • Pharmaceuticals & Biopharmaceuticals Market Sales by Geography (USD MN)
  • Cosmetic & Household Products Market Sales by Geography (USD MN)
  • Food Market Sales by Geography (USD MN)
  • Chemicals Market Sales by Geography (USD MN)
  • Global Market Analysis by Technology (USD MN)
  • Cell Culture Technologies Market Sales by Geography (USD MN)
  • High-throughput Technologies Market Sales by Geography (USD MN)
  • Toxicogenomics Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.